Skip to main content

Maligne Tumoren des Corpus uteri

  • Chapter
Gynäkologische Onkologie

Zusammenfassung

Die malignen Tumoren des Corpus uteri umfassen grundsätzlich zwei Gruppen:

  • Endometriumkarzinome,

  • Sarkome des Corpus uteri.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aalders J, Abeler V, Kolstad P, Onsrud M (1980) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Obstet Gynecol 56: 419–427

    PubMed  CAS  Google Scholar 

  • Aalders J, Abeler V, Kolstad P (1984) Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Gynecol Oncol 17: 85

    PubMed  CAS  Google Scholar 

  • Anderson B, Marchant DJ, Munzenrider JE, Moore JP, Mitchell GW (1976) Routine noninvasive hysterography in the evaluation and treatment of endometrial carcinoma. Gynecol Oncol 4: 354–367

    PubMed  CAS  Google Scholar 

  • Averette HE, Donate DM, Lovecchio JL, Sevin BU (1987) Surgical staging of gynecologic malignancies. Cancer 60: 2010–2020

    PubMed  CAS  Google Scholar 

  • Ayoub J, Audet-Lapointe J, Method V et al (1985) Effectiveness of cyclical hormonal therapy in endometrial cancer and its correlation with estrogen-receptor status. Proc Am Soc Clin Oncol 4: 114

    Google Scholar 

  • Baltzer J, Lohe KJ (1986) Präneoplasien und Karzinome des Endometriums. In: Schmidt- Matthiesen H (Hrsg) Klinik der Frauenheilkunde und Geburtshilfe, Bd 11. Spezielle gynäkologische Onkologie I. Urban & Schwarzenberg, München, S 231–263

    Google Scholar 

  • Baltzer J, Wolf W, Lohe KJ (1974) Die diagnostische Saug-Kürettage des Uterus. Frauenarzt 3: 194–195

    Google Scholar 

  • Barber HRK (1982) Cancer of the endometrium. In: van Nageil JR, Barber HRK (eds) Modem concepts of gynecologic oncology. Wright, Boston

    Google Scholar 

  • Bauer M (1987) Zur intrakavitären Brachytherapie mit Lang- und Kurzzeit-Afterloading-Technik in der Gynäkologie. Gynäkologe 20: 228–236

    PubMed  CAS  Google Scholar 

  • Bean HA, Bryant AJS (1978) Carcinoma of the endometrium in Saskatchewan: 1966–1971. Gynecol Oncol 6: 503

    PubMed  CAS  Google Scholar 

  • Boronow RC, Morrow CP, Creasman WT, DeSaia PJ, Silverberg SG, Miller A, Blessing JA (1984) Surgical staging in endometrial cancer: clinical-pathological findings of a prospective study. Obstet Gynecol 83: 825–828

    Google Scholar 

  • Boutselis JG, Ullery JC, Bair J (1963) Vaginal metastases following treatment of endometrial carcinoma. Obstet Gynecol 51: 339

    Google Scholar 

  • Bremen T, Waibel S, Leydendecker G (1989) Tumorremission eines endometrialen Stromasarkoms nach Behandlung mit GnRH-Analoga. In: Ludwig H, Krebs D (Hrsg) Gynäkologie und Geburtshilfe 1988: Springer, Berlin Heidelberg New York Tokyo, S 585–586

    Google Scholar 

  • Bruckmann JE, Goodman RL, Murthy A, Marek A (1979) Combined irradiation and surgery in the treatment of stage II carcinoma of the endometrium. Obstet Gynecol Surv 34:245– 247

    Google Scholar 

  • Brunner KW (1985) Die internistische Therapie des metastasierenden Mammakarzinoms. In: Büchner T, Urbanitz D, van de Loo J (Hrsg) Therapie des Mammakarzinoms. Springer, Berlin Heidelberg New York Tokyo, S 51

    Google Scholar 

  • Brunner KW (1987) Effects and side effects of chemotherapy in endometrial cancer. In: Schulz KD, King RJB, Poliow K, Taylor RW (eds) Endometrial cancer. Zuckschwerdt, München, pp 181–190

    Google Scholar 

  • Buchsbaum HJ, Lifshitz S, Blythe JG (1976) Prophylactic chemotherapy in stages I and II uterine sarcoma. Gynecol Oncol 8: 346

    Google Scholar 

  • Butler EB (1976) The early diagnosis of cancer of the endometrium. Clin Obstet Gynecol 3: 389–405

    CAS  Google Scholar 

  • Carlson JA, Allegra JC, Day TG, Wittliff JL (1984) Tamoxifen and endometrial carcinoma: Alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia. Am J Obstet Gynecol 149: 149–153

    Google Scholar 

  • Cavalli F, Beer M, Martz G, Jungi WF et al. (1983) Concurrent or sequential use of cytotoxic chemotherapy and hormone treatment in advanced breast cancer: Report of the Swiss Group for Clinical Cancer Research. Br Med J 286: 5–8

    CAS  Google Scholar 

  • Clarke M (1978) Cancer of the endometrium: epidemiology. In: Brush MG, King RJB,Taylor RW (eds) Endometrial cancer. Bailliére Tindall, London

    Google Scholar 

  • Cohen G et al. (1984) A randomized study comparing multi-drug chemotherapeutic regimes in the treatment of advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Obstet Gynecol 63: 719

    PubMed  CAS  Google Scholar 

  • Cramer DW, Cutler SJ (1974) Incidence and histopathology of malignancies of the female genital organs in the United States. Am J Obstet Gynecol 118: 443

    PubMed  CAS  Google Scholar 

  • Creasman WT, Boronow RC, Morrow CP, DiSaia PJ, Blessing J (1976) Adenocarcinoma of the endometrium: its metastatic lymph node potential. Gynecol Oncol 4: 239–243

    PubMed  CAS  Google Scholar 

  • Creasman WT, McCarty KS, Barton TK (1980) Clinical correlates of estrogen- and progesterone-binding proteins in human endometrial adenocarcinoma. Obstet Gynecol 55: 363–370

    PubMed  CAS  Google Scholar 

  • Creasman WT, Henderson D, Hinshaw W, Clarke-Pearson DL (1986) Estrogen replacement therapy in the patients treated for endometrial cancer. Obstet Gynecol 67: 326

    PubMed  CAS  Google Scholar 

  • Creasman WT, Morrow CP, Bundy L (1987) Surgical pathological spread patterns of endometrial cancer. Cancer 60: 2035

    PubMed  CAS  Google Scholar 

  • Dallenbach-Hellweg GH, Poulsen H (1985) Tumoren. In: Dallenbach-Hellweg GH, Poulsen H (Hrsg) Atlas der Histopathologic des Endometriums. Springer, Berlin Heidelberg New York, S 166–218

    Google Scholar 

  • Dallenbach-Hellweg GH, Schmidt-Matthiesen H (1983) Hyperplasien, Präkanzerosen und Karzinome des Endometriums. Dtsch Ges Gynäkologie Geburtshilfe Mitteilg 7: 13–15

    Google Scholar 

  • Deppe G (1984) Chemotherapy of endometrial carcinoma. In: Deppe G (ed) Chemotherapy of gynecologic cancer. Liss, New York, pp 139–150

    Google Scholar 

  • DiSaia PJ, Creasman WT (1989a) Adenocarcinoma of the uterus. In: DiSaia PJ, Creasman WT (eds) Synopsis of gynecologic oncology. Mosby, St. Louis, pp 161–197

    Google Scholar 

  • DiSaia PJ, Creasman WT (1989b) Endometrial hyperplasia. In: DiSaia PJ, Creasman WT (eds) Clinical gynecologic oncology. Mosby, St. Louis, pp 143–160

    Google Scholar 

  • DiSaia PJ, Creasman WT (1989c) Sarcoma of the uterus. In: DiSaia PJ, Creasman WT (eds) Clinical gynecologic oncology. Mosby, St. Louis, pp 198–213

    Google Scholar 

  • Ehrlich CE, Cleary RE, Young PCM (1978) The use of progesterone receptors in the management of recurrent endometrial cancer. In: Brush MG, King RJB, Raylor RW (eds) Endometrial cancer. Bailliére-Tindall, London

    Google Scholar 

  • Ehrlich CE, Young PCM, Stehman FB, Sutton GP, Alford WM (1988) Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. Am J Obstet Gynecol 158: 796–805

    PubMed  CAS  Google Scholar 

  • Fournier D v, Junkermann H, Anton HW (1987) Indikation zur Radiotherapie beim Kollum-und Korpuskarzinom nach Operation. Gynäkologe 20: 222–227

    Google Scholar 

  • Friedman W (1988) Erkrankungen des Corpus uteri. In: Martius G (Hrsg) Therapie in Geburtshilfe und Gynäkologie, Bd II: Gynäkologie. Thieme, Stuttgart, S 173–186

    Google Scholar 

  • Frischkorn R (1981a) Die Nachbestrahlung des operierten Zervix- und Endometriumkarzinoms. 43. Vers Dtsch Ges Gynäkol Geburtshilfe. Arch Gynäkol 232: 175

    Google Scholar 

  • Frischkorn R (1981b) Indikationen der postoperativen Strahlenbehandlung beim Zervix- und Endometriumkarzinom. In: Wannenmacher M (Hrsg) Kombinierte chirurgische und radiologische Therapie maligner Tumoren. Urban & Schwarzenberg, München Wien Baltimore, S 280

    Google Scholar 

  • Frischkorn R (1983) Die Strahlentherapie des Endometriumkarzinoms. Gynäkologe 16: 104 113

    Google Scholar 

  • Gilbert H, Kagan AR, Lagasse L, Jacobs MR (1975) The value of radiation therapy in uterine sarcoma. Obstet Gynecol 45: 84

    PubMed  CAS  Google Scholar 

  • Griesinger RA, Schindler A (1986) Therapie mit Gestagenen bei hyperplastischen Veränderungen des Endometriums. Geburtshilfe Frauenheilkd 46: 690

    PubMed  CAS  Google Scholar 

  • Gravlee LC (1977) Jet-irrigation method for a diagnosis of endometrial adenocarcinoma: its principle and accuracy. Obstet Gynecol 49: 385–389

    Google Scholar 

  • Grimshaw RN, Tupper WC, Fräser RC, Tompkins MG, Jeffrey JF (1990) Prognostic value of peritoneal cytology in endometrial carcinoma. Gynecol Oncol 36: 97–100

    PubMed  CAS  Google Scholar 

  • Hacker NF (1989) Uterine cancer. In: Berek JS, Hacker NF (eds) Practical gynecologic oncology. Williams & Wilkins, Baltimore, pp 285–326

    Google Scholar 

  • Haller U, Kubli F, Bräunig G, Müller H, Castaño y Almendral A (1973) Die diagnostische Aspirationskürettage. Geburtshilfe Frauenheilkd 33: 1–13

    CAS  Google Scholar 

  • Hendrickson M et al. (1982) Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6: 93–108

    PubMed  CAS  Google Scholar 

  • Higdon RE, Averette HE, Donato DM, Penalver MA, Sevin BU (1991) Endometrial cancer: treatment of advanced or recurrent disease with cyclophosphamide, doxorubicin, cis- platinum and megestrol acetate chemotherapy. Obstet Gynecol (in press)

    Google Scholar 

  • Iversen OE, Segadal E (1985) The value of endometrial cytology. A comparative study of the Gravlee Jet-Washer, Isaacs Cell Sampler and Endoscan versus curettage in 600 patients. Obstet Gynecol Surv 40: 14–20

    PubMed  CAS  Google Scholar 

  • Jones HW (1975) Treatment of adenocarcinoma of the endometrium. Obstet Gynecol Surv 30: 147

    PubMed  Google Scholar 

  • Jordan VC (1987) Antioestrogen for the treatment of endometrial cancer. In: Schulz KD, King RJB, Pollow K, Taylor RW (eds) Endometrial cancer. Zuckschwerdt, München, pp 157–164

    Google Scholar 

  • Kahanpaa KV, Wahlstom T, Grohn P et al. (1986) Sarcoma of the uterus: a clinicopathologic study of 119 patients. Obstet Gynecol 67: 417

    PubMed  CAS  Google Scholar 

  • Käser O (1983) Operative Möglichkeiten bei der Therapie des Endometriumkarzinoms. Gynäkologe 16: 99–103

    PubMed  Google Scholar 

  • Käser O (1986) Kommentar zur primär operativen Therapie des Korpuskarzinoms. Gynäkologe 19: 94–95

    Google Scholar 

  • Kaunitz AM, Mosciello A, Ostrowski M, Rovira EZ (1988) Comparison of endometrial biopsy with the endometrial pipette and vabra aspirator. J Reprod Med 33: 427–431

    PubMed  CAS  Google Scholar 

  • Kauppila A, Vihko R (1987) Estrogen and progestin receptors as prognostic markers in endometrial cancer. In: Schulz KD, King RJB, Pollow K, Taylor RW (eds) Endometrial cancer. Zuckschwerdt, München, pp 104–111

    Google Scholar 

  • Kolstad P (1983) Adjuvant chemotherapy in sarcoma of the uterus: a preliminary report. In: Morrow CP et al. (eds) Recent clinical developments in gynecologic oncology. Raven Press, New York, pp 123–129

    Google Scholar 

  • Kolstad P (1987) The role of radiation in the treatment of endometrial cancer. In: Schulz KD, King RJB, Pollow K, Taylor RW (eds) Endometrial cancer. Zuckschwerdt, München, pp 129–135

    Google Scholar 

  • Komaki R (1989) The endometrium. In: Moss WT, Cox JD (eds) Radiation oncology. Mosby, St. Louis, Baltimore Toronto, pp 559–580

    Google Scholar 

  • Koss LG, Schreiber K, Oberlander SG, Moukhtar M, Levine HS, Moussouris HF (1981) Screening of asymptomatic women for endometrial cancer. Obstet Gynecol 57: 681–691

    PubMed  CAS  Google Scholar 

  • Kurman RJ, Norris HJ (1987) Endometrial hyperplasia and metaplasia. In: Kurman RJ (ed) Blaustein’s pathology of the female genital tract. Springer, New York Berlin Heidelberg, pp 322–337

    Google Scholar 

  • Lauritzen C (1987) Exogenous hormones and endometrial carcinogenesis. In: Schulz KD, King RJB, Pollow K, Taylor RW (eds) Endometrial cancer. Zuckschwerdt, München, pp 9–20

    Google Scholar 

  • Leppien G (1986) Sarkome der weiblichen Genitalorgane. In: Schmidt-Matthiesen H (Hrsg) Klinik der Frauenheilkunde und Geburtshilfe, Bd 11. Spezielle gynäkologische Onkologie I. Urban & Schwarzenberg, München, S 265–281

    Google Scholar 

  • Lindemann HJ (1980) Atlas der Hysteroskopie. Fischer, Stuttgart

    Google Scholar 

  • Lochmüller H (1978) Das Endometriumkarzinom als chronische Erkrankung. Wachholz, Nürnberg

    Google Scholar 

  • Lohe KJ, Baltzer J (1981) Weibliche Genitaiorgane Teil I. In: Hermanek P (Hrsg) Kompendium der klinischen Tumorpathologie, Bd 3. Witzstrock, Baden-Baden

    Google Scholar 

  • Lohe KJ, Baltzer J, Wolf W, Kürzl R, Tschebiner H (1979) Zur Klinik des Uterussarkoms. Arch Gynecol 228: 651–652

    PubMed  CAS  Google Scholar 

  • Lohe KJ, Baltzer J, Wolf W, Kürzl R, Tschebiner H (1980) Clinical results in management of patients with uterine sarcomas. Pathol Res Pract 169: 200

    PubMed  CAS  Google Scholar 

  • Long HJ et al. (1988) Phase II evaluation of carboplatin in advanced endometrial carcinoma. JNCI 80: 276

    CAS  Google Scholar 

  • Lovecchio JL, Averette HE, Lichtinger M, Townsend PA, Girtanner RW, Fenton AN (1984) Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-platinum, and megestrol acetate. Obstet Gynecol 63: 557

    PubMed  CAS  Google Scholar 

  • Maass H (1987) Epidemiology and etiology. In: Schulz KD, King RJB, Pollow K, Taylor R (eds) Endometrial cancer. Zuckschwerdt, München, pp 3–8

    Google Scholar 

  • Malkasian GD, Annegeres JF, Fountain FS (1980) Carcinoma of the endometrium: stage I. Am J Obstet Gynecol 136: 872–883

    PubMed  Google Scholar 

  • Marchetti DL, Piver MS, Tsukada Y, Reese P (1986) Prevention of vaginal recurrence of stage I endometrial adenocarcinoma with postoperative vaginal radiation. Obstet Gynecol 67: 399–402

    PubMed  CAS  Google Scholar 

  • Mazurka JL, Krepart GV, Lotocki RJ (1988) Prognostic significance of positive peritoneal cytology in endometrial carcinoma. Am J Obstet Gynecol 158: 303–306

    PubMed  CAS  Google Scholar 

  • Mestwerdt W, Kranzfelder D (1983) Neue diagnostische Möglichkeiten beim Endometriumkarzinom und seinen Vorstufen. Gynäkologe 16: 87–92

    PubMed  CAS  Google Scholar 

  • Morrow CP, Townsend DE (1987) Tumors of the endometrium. In: Morrow CP, Townsend DE (eds) Synopsis of gynecologic oncology. Churchill Livingstone, New York, pp 159– 205

    Google Scholar 

  • Morrow CP, DiSaia PJ, Townsend DE (1973) Current management of endometrial carcinoma. Obstet Gynecol 42: 399

    PubMed  CAS  Google Scholar 

  • Muss HB, Bundy B, DiSaia PJ (1985) Treatment of recurrent or advanced uterine sarcomas: A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase in trial of the Gynecologic Oncology Group). Cancer 55:

    Google Scholar 

  • Nagell JR van et al. (1986) Adjuvant vincristine, dactinomycin, and cyclophosphamide therapy in stage I uterine sarcomas. Cancer 57: 1451

    PubMed  Google Scholar 

  • Omura GA et al. (1983) A randomized study of adriamycin with and without dimethyl triazeno-imidazol carboxamide in advanced uterine sarcomas. Cancer 52: 626

    PubMed  CAS  Google Scholar 

  • Omura GA et al. (1985) A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group study. J Clin Oncol 9: 1240

    Google Scholar 

  • Onsrud M, Aalders J, Abeler V, Taylor P (1982) Endometrial carcinoma with cervical involvement (stage II): prognostic factors and value of combined radiological-surgical treatment. Gynecol Oncol 13: 76–86

    PubMed  CAS  Google Scholar 

  • Pasmantier MW, Coleman M, Silver RT, Mamril AP, Quiguyan CC, Galindo A (1984) Treatment of advanced endometrial carcinoma with doxorubicin and cisplatin: effects on both untreated and previously treated patients. Cancer Treat Rep 69: 539–542

    Google Scholar 

  • Pettersson F, Kolstad P, Ludwig H, Ulfelder H (1985) Annual report on the results of treatment in gynecological cancer. Radiumhemmet, Stockholm, p 19

    Google Scholar 

  • Pfleiderer A (1981) Die Kombination von Operation und Strahlentherapie aus der Sicht des Operateurs beim Ovarial- und Endometriumkarzinom. In: Wannenmacher M (Hrsg) Kombinierte chirurgische und radiologische Therapie maligner Tumoren. Urban & Schwarzenberg, München

    Google Scholar 

  • Pfleiderer A, Kleine W (1987) Surgical methods and significance of different prognostic criteria. In: Schulz KD, King RJB, Pollow K, Taylor RW (eds) Endometrial cancer. Zuckschwerdt, München, pp 119–135

    Google Scholar 

  • Piver MS, Marchetti DL (1989) Endometrial carcinoma. In: Piver MS (ed) Manual of gynecologic oncology and gynecology. Little, Brown, Boston, pp 87–101

    Google Scholar 

  • Piver MS, Rose PG (1988) Advanced uterine sarcomas: response to chemotherapy. Eur J Gynecol Oncol 9: 124

    CAS  Google Scholar 

  • Piver MS et al. (1982) Cyclophosphamide, vincristine, adriamycin and dimethyl-triazeno- imidazol carboxamide (CYVADIC) for sarcomas of the female genital tract. Gynecol Oncol 14: 319

    PubMed  CAS  Google Scholar 

  • Piver MS, Rutledge FN, Copeland L, Webster K et al. (1984) Uterine endolymphatic stromal myosis. A collaborative study. Obstet Gynecol 64: 173

    CAS  Google Scholar 

  • Piver MS et al. (1988) The effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas. J Surg Oncol 38: 233

    PubMed  CAS  Google Scholar 

  • Potish et al. (1987) Radiation of periaortic node metastases in cancer of the uterine cervix and endometrium. Radiology 165: 567–570

    PubMed  CAS  Google Scholar 

  • Rose PG (1989) Uterine sarcoma. In: Piver MS (ed) Manual of gynecologic oncology and gynecology. Little, Brown, Boston, pp 102–116

    Google Scholar 

  • Rubens RD, Begent RHJ, Knight RK, Sexton SA, Hayward JL (1978) Combined cytotoxic and progesterone therapy for advanced breast cancer. Cancer 42: 1680–1686

    PubMed  CAS  Google Scholar 

  • Salazar OM, Dunne ME (1980) The role of radiation therapy in the management of uterine sarcomas. Int J Radiat Oncol Bio Phys 6: 899

    CAS  Google Scholar 

  • Salazar OM, Bonfiglio TA, Patten SF, Keller BE, Feldstein ML, Dunne ME, Rudolph JH (1978a) Uterine sarcomas. Analysis of failures with special emphasis on the use of adjuvant radiation therapy. Cancer 42: 1161

    Google Scholar 

  • Salazar OM, Bonfiglio TA, Patten SF, Keller BE, Feldstein M, Dunne ME, Rudolph JH (1978b) Uterine sarcomas. Natural history, treatment and prognosis. Cancer 42: 1152

    Google Scholar 

  • Samartzis S, Hauser GA (1976) Die Postmenopauseblutung. Geburtsh Frauenheilk 36:326– 333

    Google Scholar 

  • Schmidt-Matthiesen H (1987) Endometrium-(Korpus)-Karzinom. In: Schmidt-Matthiesen H, Bastert G (Hrsg) Gynäkologische Onkologie. Schattauer, Stuttgart, S 46–66

    Google Scholar 

  • Schulz KD, Kaiser R (1983) Gegenwärtiger Stand der medikamentösen Behandlung des Endometriumkarzinoms. Gynäkologe 16: 114–118

    PubMed  CAS  Google Scholar 

  • Schulz KD, Schmidt-Rhode P, Zippel HH, Sturm G (1987) New concepts of adjuvant drug treatment in endometrial cancer. In: Schulz KD, King RJB, Pollow K, Taylor RW (eds) Endometrial cancer. Zuckschwerdt, München, pp 169–180

    Google Scholar 

  • Sevin BU (1986) Primär operative Therapie des Korpuskarzinoms. Gynäkologe 19:88– 93

    Google Scholar 

  • Sevin BU (1987) Paraaortic lymph node dissection in surgical staging of endometrial carcinoma. In: Takagi S, Friedberg V, Haller U, Knapstein PG, Sevin BU (eds) Gynecologic oncology, surgery and urology. Central Foreign Books, Tokyo, pp 184–189

    Google Scholar 

  • Sevin BU (1988) Die prätherapeutische Staginglaparotomie. In: Hepp H, Scheidel P, Monaghan JM (Hrsg) Lymphonodektomie in der gynäkologischen Onkologie. Urban & Schwarzenberg, München, S 19–31

    Google Scholar 

  • Shepherd JH (1989) Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol 96: 889–892

    PubMed  CAS  Google Scholar 

  • Silverberg SG (1989) Carcinosarcoma of the uterus. Int J Gynecol Pathol 9: 1–19

    Google Scholar 

  • Smith JP et al. (1975) Combined irradiation and chemotherapy for sarcomas of the pelvis in females. AJR 123: 571

    CAS  Google Scholar 

  • Stegner HE (1980) Clinical aspects of uterine sarcomas. Pathol Res Pract 169: 120

    PubMed  CAS  Google Scholar 

  • Stoll P, Lutz H, Runnebaum B, Wittlinger H (1977) Gynäkologische Erkrankungen im Klimakterium und im Senium. Deutscher Ärzteverlag, Köln

    Google Scholar 

  • Sutton GP et al. (1987) Malignant papillary lesions of the endometrium. Gynecol Oncol 27: 294

    PubMed  CAS  Google Scholar 

  • Sutton G, Blessing J, McGurie W, Photopulos G, Rettenmaier M et al. (1988) Phase II trial of ifosphamide and mesna in patients with recurrent or advanced mixed mesodermal tumors of the uterus. Proc Am Soc Clin Oncol 7: 137

    Google Scholar 

  • Swenerton KD (1987) The treatment of disseminated endometrial carcinoma with tamoxifen. In: Schulz KD, King RIB, Pollow K, Taylor (eds) Endometrial cancer. Zuckschwerdt, München, pp 165–168

    Google Scholar 

  • Teufel G, Frauer A, Eberl M, Pfleiderer A, Neunhoeffer J (1980) Sarcomas of the female genitalia. Therapy and prognosis. Pathol Res Pract 169: 173

    PubMed  CAS  Google Scholar 

  • Thigpen JT, Buchsbaum HJ, Mangan C, Blessing JA (1979) Phase II trial of adriamycin in the treatment of advanced or recurent endometrial carcinoma: a Gynecologic Oncology Group study. Cancer Treat Rep 63: 17–21

    Google Scholar 

  • Thigpen T, Vance R, Lambuth B, Ablducci L, Khansur T, Blessing J, McGehee R (1987) Chemotherapy for advanced or recurrent gynecologic cancer. Cancer 60: 2104–2116

    PubMed  CAS  Google Scholar 

  • Toppozada MK, Ismail AAA, Hamed RSM, Ahmed KS, El-Fares A (1988) Progesteron challenge test and estrogen assays in menopausal women with endometrial adenomatous hyperplasia. Int J Gynecol Obstet 26: 115–119

    CAS  Google Scholar 

  • Vergote I, Korstad K, Abeler V, Kolstad P (1989) A randomized trial of adjuvant progesteron in early endometrial cancer. Cancer 64: 1011–1016

    PubMed  CAS  Google Scholar 

  • Wyss R, Vassilakos P, Riotton G (1975) Eine neue Aspirationsmethode mit dem Pistolet (zur Früherkennung endometrialer Veränderungen). Geburtshilfe Frauenheilkd 35: 846–853

    PubMed  CAS  Google Scholar 

  • Zaloudek C, Norris HJ (1987) Mesenchymal tumors of the uterus. In: Kurman RJ, Norris HJ (eds) Blaustein’s pathology of the female genital tract. Springer, New York Berlin Heidelberg, pp 371–408

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Köchli, O.R., Sevin, BU., Benz, J., Petru, E., Haller, U. (1991). Maligne Tumoren des Corpus uteri. In: Gynäkologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97274-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-97274-4_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-97275-1

  • Online ISBN: 978-3-642-97274-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics